AVITA Medical, Inc. (RCEL)
16.80
+1.03
(+6.53%)
USD |
NASDAQ |
Nov 18, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
AVITA Medical Total Return Level : 15.77 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 15.77 |
| November 16, 2026 | 15.22 |
| November 13, 2026 | 15.63 |
| November 12, 2026 | 16.20 |
| November 11, 2026 | 17.30 |
| November 10, 2026 | 17.65 |
| November 09, 2026 | 17.12 |
| November 06, 2026 | 16.59 |
| November 05, 2026 | 15.68 |
| November 04, 2026 | 16.32 |
| November 03, 2026 | 15.33 |
| November 02, 2026 | 15.41 |
| October 30, 2026 | 15.65 |
| October 29, 2026 | 16.71 |
| October 28, 2026 | 16.50 |
| October 27, 2026 | 16.08 |
| October 26, 2026 | 15.18 |
| October 23, 2026 | 15.51 |
| October 22, 2026 | 15.42 |
| October 21, 2026 | 15.29 |
| October 20, 2026 | 13.80 |
| October 19, 2026 | 13.14 |
| October 16, 2026 | 13.04 |
| October 15, 2026 | 13.41 |
| October 14, 2026 | 13.10 |
| Date | Value |
|---|---|
| October 13, 2026 | 13.36 |
| October 12, 2026 | 13.37 |
| October 09, 2026 | 13.21 |
| October 08, 2026 | 13.33 |
| October 07, 2026 | 13.05 |
| October 06, 2026 | 12.99 |
| October 05, 2026 | 13.25 |
| October 02, 2026 | 12.72 |
| October 01, 2026 | 12.01 |
| September 30, 2026 | 11.73 |
| September 29, 2026 | 11.96 |
| September 28, 2026 | 11.67 |
| September 25, 2026 | 11.84 |
| September 24, 2026 | 11.58 |
| September 23, 2026 | 10.95 |
| September 22, 2026 | 11.49 |
| September 21, 2026 | 10.84 |
| September 18, 2026 | 11.02 |
| September 17, 2026 | 11.22 |
| September 16, 2026 | 10.45 |
| September 15, 2026 | 10.21 |
| September 14, 2026 | 10.19 |
| September 11, 2026 | 9.88 |
| September 10, 2026 | 9.86 |
| September 09, 2026 | 10.16 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Iovance Biotherapeutics, Inc. | 7.53 |
| Halozyme Therapeutics, Inc. | 95.97 |
| Agenus, Inc. | 6.21 |
| Amgen, Inc. | 685.72 |
| Fate Therapeutics, Inc. | 1.02 |